Citizens National Bank Trust Department Has $7.67 Million Stake in Procter & Gamble Company (The) $PG

Citizens National Bank Trust Department lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,149 shares of the company’s stock after selling 553 shares during the period. Procter & Gamble makes up 1.5% of Citizens National Bank Trust Department’s portfolio, making the stock its 19th biggest position. Citizens National Bank Trust Department’s holdings in Procter & Gamble were worth $7,671,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Benjamin Edwards Inc. raised its position in shares of Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after purchasing an additional 199,258 shares during the period. Capital Investment Advisory Services LLC increased its stake in Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after purchasing an additional 4,562 shares in the last quarter. World Investment Advisors raised its holdings in Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after buying an additional 2,886 shares during the period. Concurrent Investment Advisors LLC lifted its stake in Procter & Gamble by 26.4% in the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after buying an additional 25,059 shares in the last quarter. Finally, Kelly Financial Services LLC boosted its holdings in shares of Procter & Gamble by 8.7% in the first quarter. Kelly Financial Services LLC now owns 1,727 shares of the company’s stock valued at $294,000 after buying an additional 138 shares during the period. 65.77% of the stock is owned by institutional investors.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of the firm’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This trade represents a 3.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the transaction, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Company insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the topic of several research reports. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a “buy” rating in a research report on Wednesday, July 30th. BNP Paribas Exane cut their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Berenberg Bank increased their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, Barclays lowered their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $173.11.

Procter & Gamble Price Performance

Shares of PG opened at $152.60 on Wednesday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company’s fifty day simple moving average is $155.30 and its 200 day simple moving average is $159.79. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a market cap of $357.16 billion, a price-to-earnings ratio of 23.44, a PEG ratio of 4.13 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.